Sari Yordi

Sari Yordi

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
SYSari Yordi
Sari Yordi
YCYavuz Cakir
Yavuz Cakir
Gagan KalraGagan Kalra
Gagan Kalra
HCHasan Cetin
Hasan Cetin
Ming HuMing Hu
Ming Hu
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
In this longitudinal retrospective image analysis, conducted on patients diagnosed with dry age-related macular degeneration (AMD) and 5 years of follow-up imaging data, the study aimed to investigate the relationship between ellipsoid zone (EZ) integrity on spectral domain optical coherence tomography (SD-OCT) and visual acuity (VA). Using a machine learning-enabled feature extraction tool, quantitative EZ parameters were derived from SD-OCT images. The analysis revealed significant correlations between EZ integrity metrics and VA. Eyes with excellent VA (≥20/25 Snellen) exhibited higher EZ integrity, including less EZ attenuation, thicker ellipsoid zone-retinal pigment epithelium (EZ-RPE) thickness, and higher EZ intensity, in contrast to eyes with worse VA (≤20/40 Snellen). Additionally, eyes with geographic atrophy (GA) in the foveal region displayed compromised EZ integrity compared to those without GA. Notably, baseline EZ integrity metrics were predictive of future VA loss. These findings suggest that quantitative SD-OCT measurements of EZ integrity could potentially detect early changes in dry AMD and serve as valuable indicators for predicting future functional outcomes. Furthermore, these measurements hold promise for use in clinical trial screenings, offering insights into the progression of the disease and its impact on visual acuity. This study underscores the importance of EZ integrity assessment in understanding and managing dry AMD.

1 July 2021 in Survey of Ophthalmology
Verified
Journal Article
Closed access
SYSari Yordi
Sari Yordi
HSHansell Soto
Hansell Soto
RBRandy C. Bowen
Randy C. Bowen
Arun d SINGHArun d SINGH
Arun d SINGH

1 February 2023 in Ophthalmology Retina
Verified
Journal Article
Open access
KSKubra Sarici
Kubra Sarici
SYSari Yordi
Sari Yordi
AMAlison Martin
Alison Martin
LLLeina Lunasco
Leina Lunasco
CMChristopher Mugnaini
Christopher Mugnaini
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
The purpose of this study was to evaluate the longitudinal change in quantitative ultrawide-field angiographic (UWFA) parameters and correlate them with functional outcomes and spectral domain-OCT metrics. This study is a post hoc analysis of the phase II RUBY study: a prospective, randomized trial of patients with diabetic macular edema (DME) treated with either intravitreal aflibercept injection (IAI) or combined IAI/nesvacumab (antiangiopoietin 2 mAb). Subjects with DME that underwent UWFA across all treatment groups (n = 44). A machine learning-enabled feature extraction system generated panretinal quantitative UWFA metrics, including leakage, ischemia, and microaneurysm (MA) burden. Zonal assessments were performed corresponding to the macula, midperiphery, and far periphery. Changes in ischemic area and index (proportion of nonperfusion in analyzable retina), leakage area and index (proportion of leakage in analyzable retina), and MA count at baseline, week 12, week 24, and week 36 were analyzed. Spectral-domain-OCT quantitative metrics, such as central subfield thickness, ellipsoid zone (EZ) integrity parameters, intraretinal fluid (IRF) volume, and subretinal fluid (SRF) volume were extracted via a machine learning-enhanced OCT feature extraction platform and analyzed. Additionally, the effect of these changes on best-corrected visual acuity (BCVA) was evaluated. Mean panretinal leakage index, zonal leakage area, and panretinal MA count improved significantly between baseline and week 36. Panretinal ischemic index decreased between baseline and week 36, with some aspects showing significant improvement. Mean BCVA significantly improved from baseline to week 36. There was a significant inverse correlation between change in BCVA and change in macular leakage area. A direct correlation was observed between both baseline macular leakage area and panretinal leakage index with IRF volume, SRF volume, and EZ disruption on OCT. Assessment of UWFA parameters demonstrates a significant improvement in panretinal leakage index, leakage area, and MA burden in eyes treated with IAI with or without nesvacumab. A numeric reduction in panretinal ischemic index and area was noted. The analysis also shows the critical association of leakage with visual and OCT features. This highlights the potential role of UWFA in disease burden assessment, with leakage parameters serving as a primary end point. Proprietary or commercial disclosure may be found after the references.

13 February 2024 in Ophthalmology Retina
Verified
Journal Article
Open access
SYSari Yordi
Sari Yordi
YCYavuz Cakir
Yavuz Cakir
HCHasan Cetin
Hasan Cetin
KTKatherine E. Talcott
Katherine E. Talcott
SSSunil K. Srivastava
Sunil K. Srivastava
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
To evaluate the incidence of bacillary layer detachment in patients with neovascular age-related macular degeneration (nAMD) and their response to anti-vascular endothelial growth factor (VEGF) therapy DESIGN: Post-hoc analysis of the brolucizumab 6-mg and aflibercept 2-mg arms from the HAWK clinical trial, a 48-week, prospective, double-masked, phase 3 trial PARTICIPANTS: Participants (n=652 and 652 eyes) randomized to brolucizumab 6-mg and aflibercept 2-mg arms from HAWK (NCT02307682) METHODS: SD-OCT scans were obtained at 4-week intervals throughout HAWK trial and segmented automatically using a proprietary, machine learning-enabled, higher-order feature extraction platform MAIN OUTCOME MEASURES: The incidence of bacillary layer detachment and effect of anti-VEGF therapy in these eyes on best corrected visual acuity (BCVA), central subfield thickness (CST), retinal fluid volumes, subretinal hyperreflective material (SHRM) volume, and ellipsoid zone (EZ) integrity from baseline to week 48 RESULTS: Classic bacillary layer detachment was identified in 7.2% (47/652) of eyes, demonstrating worse BCVA and higher CST, EZ total attenuation, subretinal fluid (SRF), and SHRM volume at baseline than eyes without bacillary layer detachment. Anti-VEGF treatment resulted in resolution of bacillary layer detachment in 97.9% of eyes by week 48. In eyes with bacillary layer detachment, anti-VEGF treatment improved BCVA and decreased SRF and SHRM volume; however, eyes with bacillary layer detachment never reached the level of BCVA improvement as eyes without bacillary layer detachment. A greater proportion of eyes with bacillary layer detachment had high exudative volatility (increased mean SD after loading dose) of CST, SRF, and total fluid than eyes without bacillary layer detachment (P < .05 for each comparison) CONCLUSION: Bacillary layer detachment an OCT signature representing photoreceptor schisis is identifiable in a notable proportion of eyes with nAMD. Anti-VEGF therapy resulted in a very high proportion of bacillary layer detachment resolution with significantly decreased SRF and SHRM volumes. The majority of eyes with bacillary layer detachment have high exudative volatility, which may be associated with lower BCVA outcomes. The presence of bacillary layer detachment may provide an important imaging biomarker to be considered for clinical trial inclusion/exclusion based on trial design and therapeutic goals due to its unique behavior.

30 August 2024 in Ophthalmology Retina
Verified
Journal Article
Closed access
WNWriting Committee for the DRCR Retina Network
Writing Committee for the DRCR Retina Network
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
KJKristin Josic
Kristin Josic
SYSari Yordi
Sari Yordi
AMAlison Martin
Alison Martin
JSJenifer K Sun
Jenifer K Sun

18 July 2025 in Diagnostics
Verified
Journal Article
Open access
PDF file
Justis P. EhlersJustis P. Ehlers
Justis P. Ehlers
SYSari Yordi
Sari Yordi
HCHasan Cetin
Hasan Cetin
RAReem Amine
Reem Amine
KMKaren Matar
Karen Matar
SSSunil K. Srivastava
Sunil K. Srivastava
Background/Objectives: To investigate the effect of ellipsoid zone (EZ) integrity and retinal fluid on best-corrected visual acuity (BCVA) in neovascular, age-related macular degeneration. Methods: This was a post hoc treatment-agnostic analysis of the phase 3 HAWK trial. Intraretinal fluid (IRF), subretinal fluid (SRF), and ellipsoid zone (EZ) integrity were quantified over 48 weeks. EZ integrity maintenance was defined as EZ-RPE central subfield thickness (CST) >20 µm; partial EZ attenuation was EZ-RPE CST >0 and ≤20 µm; total EZ attenuation was EZ-RPE CST = 0 µm. Results: During treatment, BCVA in eyes with no fluid (66.5 to 70.2 letters) was greater than in eyes with IRF (59.5 to 62.4 letters) but comparable to BCVA in eyes with SRF (64.9 to 68.8 letters). In eyes with no fluid, BCVA was consistently greater in eyes with EZ integrity maintained (73.4 to 78.4 letters) than in eyes with EZ partial attenuation (65.3 to 66.5 letters) or with EZ total attenuation (55.8 to 59.8 letters). Conclusions: Eyes without fluid with EZ preservation achieved the highest overall BCVA, especially when compared to eyes without fluid and a lack of EZ preservation and to eyes with SRF. Achieving a “dry” status with preservation of EZ integrity is important in optimizing visual outcomes.